Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study

被引:1
|
作者
Couissi, Abdessamad [1 ,2 ]
Haboub, Meryem [1 ]
Hamady, Siyam [1 ]
Ettachfini, Taha [1 ]
Habbal, Rachida [1 ]
机构
[1] Ibn Rochd Univ Hosp, Cardiol Dept, Casablanca, Morocco
[2] Hassan II Univ, Fac Med & Pharm Casablanca, Casablanca, Morocco
来源
EGYPTIAN HEART JOURNAL | 2024年 / 76卷 / 01期
关键词
Heart failure; Patient readmission; Mortality; Prognosis; Morocco; TERM MORTALITY; TRIAL;
D O I
10.1186/s43044-024-00436-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Heart failure (HF) poses a significant public health challenge throughout the world and Morocco. Our objective was to delineate the epidemiological characteristics of Moroccan patients living with chronic heart failure and to identify prognostic factors correlated with CHF mortality.Results A total of 1344 patients participated in this study, with survival rates at 3, 6, and 10 years recorded at 75.2%, 60%, and 34%, respectively. During the follow-up, 886 patients succumbed, representing a mortality rate of 65.9%. A Cox regression model, utilizing baseline candidate variables, was developed to predict cardiovascular (CV) mortality. Predictors all of which had a P value less than 0.05 included age, left ventricular ejection fraction (EF) at commencement (< 35%), hypertension, male sex, anemia, creatinine levels, and the number of hospitalizations due to HF decompensation. Notably, the frequency of hospitalizations emerged as the most potent predictor of mortality, with an HR of 2.5 (95% CI [2-2.9]). Almost 90% of patients with three or more readmissions for HF decompensation experienced mortality by the follow-up's conclusion.Conclusions This study offers valuable insights into risk factors and clinical outcomes in HF patients in Morocco. Factors such as male gender, advanced age, a history of hypertension, lower systolic blood pressure, rehospitalizations for HF decompensation, low left ventricular ejection fraction, anemia, and elevated creatinine levels were associated with increased mortality. Medical and health services managers should be aware of the substantial burden and future challenges posed by HF in Morocco, prompting the adoption of multidisciplinary strategies for its management and care.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
    Abdessamad Couissi
    Meryem Haboub
    Siyam Hamady
    Taha Ettachfini
    Rachida Habbal
    The Egyptian Heart Journal, 76
  • [2] Heart failure with reduced, mildly reduced, and preserved ejection fraction: outcomes and predictors of prognosis
    Rywik, Tomasz M.
    Wisniewska, Anna
    Ceglowska, Urszula
    Drohomirecka, Anna
    Topor-Madry, Roman
    Lazarczyk, Hubert
    Polaska, Paula
    Zielinski, Tomasz
    Dorynska, Agnieszka
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (12):
  • [3] Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction
    Tian, Pengchao
    Liang, Lin
    Zhao, Xuemei
    Huang, Boping
    Feng, Jiayu
    Huang, Liyan
    Huang, Yan
    Zhai, Mei
    Zhou, Qiong
    Zhang, Jian
    Zhang, Yuhui
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (12):
  • [4] Real world medical therapy for heart failure with reduced and mildly reduced ejection fraction: REMEDI-HF study
    Fioretti, F.
    Praderio, A.
    De Angelis, M. G.
    Parola, M.
    Nodari, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 255 - 256
  • [5] Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction
    Yang, Mingming
    Kondo, T.
    Dewan, P.
    Desai, A. S.
    Lam, C. S. P.
    Lefkowitz, M. P.
    Packer, M.
    Rouleau, J. L.
    Vaduganathan, M.
    Zile, M. R.
    Jhund, P. S.
    Kober, L.
    Solomon, S. D.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 154 - 155
  • [6] Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
    Yang, Mingming
    Kondo, Toru
    Dewan, Pooja
    Desai, Akshay S.
    Lam, Carolyn S. P.
    Lefkowitz, Martin P.
    Packer, Milton
    Rouleau, Jean L.
    Vaduganathan, Muthiah
    Zile, Michael R.
    Jhund, Pardeep S.
    Kober, Lars
    Solomon, Scott D.
    Mcmurray, John J. V.
    CIRCULATION-HEART FAILURE, 2025, 18 (03)
  • [7] Clinical characteristics, predictors of mortality, and outcome in patients with heart failure with mildly reduced ejection fraction secondary to Chagas cardiomyopathy
    Bestetti, Reinaldo B.
    Otaviano, Ana Paula
    Cardinalli-Neto, Augusto
    Machado, Mauricio Nassau
    Nakazone, Marcelo A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 426
  • [8] Heterogeneity of patients phenotyped as heart failure with mildly reduced ejection fraction
    Kerkhof, P. L.
    Heyndrickx, G. R.
    Diaz-Navarro, R. A.
    Handly, N.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction
    Schupp, Tobias
    Bertsch, Thomas
    Reinhardt, Marielen
    Abel, Noah
    Schmitt, Alexander
    Lau, Felix
    Abumayyaleh, Mohammad
    Akin, Muharrem
    Weiss, Christel
    Weidner, Kathrin
    Behnes, Michael
    Akin, Ibrahim
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (11) : 1347 - 1360
  • [10] Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
    Miller, Robert J. H.
    Nabipoor, Majid
    Youngson, Erik
    Kotrri, Gynter
    Fine, Nowell M.
    Howlett, Jonathan G.
    Paterson, Ian D.
    Ezekowitz, Justin
    McAlister, Finlay A.
    ESC HEART FAILURE, 2022, 9 (03): : 1564 - 1573